EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

CDK4/6 Inhibitors and Endocrine Therapy in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A Multicenter Real-World Cohort

Daniel Marin-Trigueros, Denis U. Landaverde

World Journal of Oncology · 2026-12 · 17 (6) · 844-857

DOI: 10.14740/wjon2846 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Oncology, 2026-12. Verfasst von Daniel Marin-Trigueros und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Marin-Trigueros, D., & Landaverde, D. U. (2026). CDK4/6 Inhibitors and Endocrine Therapy in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A Multicenter Real-World Cohort. World Journal of Oncology, 17(6), 844-857. https://doi.org/10.14740/wjon2846

Vancouver

Marin-Trigueros D, Landaverde DU. CDK4/6 Inhibitors and Endocrine Therapy in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A Multicenter Real-World Cohort. World Journal of Oncology. 2026;17(6):844-857. doi:10.14740/wjon2846

BibTeX
@article{MarinTrigueros2026,
  author = {Marin-Trigueros, Daniel and Landaverde, Denis U.},
  title = {CDK4/6 Inhibitors and Endocrine Therapy in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A Multicenter Real-World Cohort},
  journal = {World Journal of Oncology},
  year = {2026},
  volume = {17},
  number = {6},
  pages = {844--857},
  doi = {10.14740/wjon2846}
}
Kostenlos starten →